Why GHK-Cu differs from other regenerative peptides Although GHK-Cu, BPC-157 and TB-500 are often grouped together as regenerative research peptides, they represent distinct biological approaches and are not directly interchangeable
Zhurnal Nevrologii i Psikhiatrii Imeni SS Korsakova, 108 (5), 71-75
All compounding occurs in our state-of-the-art, USP-compliant facility
Common Protocol: BPC-157: 250500 mcg daily, subcutaneous near injury or systemic TB500: 25 mg per week, split into 23 injections Cycle: 46 weeks, followed by reassessment 2
People also confuse GHK-Cu with other copper peptides such as AHK-Cu, or with the Acetyl Tetrapeptide-3 and Red Clover pairing
Researchers have noted that its potency in synaptic assays is orders of magnitude greater than brain-derived neurotrophic factor (BDNF), the body's primary natural driver of neuroplasticity